Testosterone supplements double men's odds for blood clots: study
(HealthDay)—Testosterone therapy appears to double a man's risk of suffering a potentially life-threatening blood clot, a new study warns.
Nov 12, 2019
0
676
(HealthDay)—Testosterone therapy appears to double a man's risk of suffering a potentially life-threatening blood clot, a new study warns.
Nov 12, 2019
0
676
Focused cardiac ultrasound (FOCUS) performed by emergency physicians with advanced training in emergency ultrasound may significantly lower the likelihood of the diagnosis of pulmonary embolism (PE) in most patients who are ...
Nov 6, 2019
0
2
(HealthDay)—The postoperative risk for pulmonary embolism extends more than six weeks for six types of surgery, according to a study published online Oct. 9 in JAMA Surgery.
Oct 15, 2019
0
2
Pulmonary embolism (PE), a blood clot lodged in one of the pulmonary arteries in the lungs, is the third leading cause of cardiovascular-related death in the United States. While most patients are treated with anticoagulants ...
Oct 5, 2019
0
4
Less than 4% of relatives of young cardiac arrest victims receive information on family screening that could prevent further deaths, according to research presented today at ESC Congress 2019 together with the World Congress ...
Sep 1, 2019
0
3
The European Society of Cardiology (ESC) Guidelines on acute pulmonary embolism are published online today in European Heart Journal. They were developed in collaboration with the European Respiratory Society (ERS).
Aug 31, 2019
0
1
Pulmonary embolism is a potentially life-threatening condition, in which blood clots migrate to arteries in the lungs, with the risk for increased pressure on the right side of the heart, impaired breathing, and even death. ...
Aug 14, 2019
0
4
(HealthDay)—Early prophylactic placement of a vena cava filter compared with no placement of a filter after major trauma does not result in a reduced incidence of symptomatic pulmonary embolism or death at 90 days, according ...
Jul 11, 2019
0
0
(HealthDay)—Fragmin (dalteparin sodium) injection has been granted the first approval for subcutaneous use in preventing recurrence of symptomatic venous thromboembolism (VTE) in children aged 1 month or older, the U.S. ...
May 17, 2019
0
1
(HealthDay)—A pregnancy-adapted algorithm can safely avoid diagnostic imaging in a proportion of pregnant women with suspected pulmonary embolism, according to a study published in the March 21 issue of the New England ...
Mar 21, 2019
0
2